Stocklytics Platform
Asset logo for symbol BHVN
Biohaven Pharmaceutical Holding Co Ltd
BHVN49
$23.40arrow_drop_up9.24%$1.97
Asset logo for symbol BHVN
BHVN49

$23.40

arrow_drop_up9.24%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Biohaven Pharmaceutical Holding Co Ltd (BHVN) Stocklytics Forecast

Biohaven Pharmaceutical Holding Co Ltd (BHVN) is a biopharmaceutical company that specializes in the development and commercialization of innovative therapies for neurological diseases. With a focus on disorders such as migraine and other neuroscience indications, Biohaven is at the forefront of medical research and drug development. The company's dedication to scientific advancement and commitment to patient care has garnered the attention of investors and analysts alike.
When it comes to predicting the stock price of Biohaven Pharmaceutical Holding Co Ltd, various factors come into play. One approach to forecasting is the use of AI and machine learning algorithms. These advanced technologies can analyze vast amounts of historical data, market trends, and other relevant information to generate predictions for future stock prices. While accurate predictions are never guaranteed, AI and machine learning can provide valuable insights for investors.
add Biohaven Pharmaceutical Holding Co Ltd to watchlist

Keep an eye on Biohaven Pharmaceutical Holding Co Ltd

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock?

Analysts have set a target price of $44.12 for Biohaven Pharmaceutical Holding Co Ltd (BHVN), based on forecasts from 24 analysts. The predicted price range extends from a high of $63 to a low of $21. This represents a potential increase of up to 169.23% and a decrease of -10.26% from the current price of $23.4. These forecasts are as of 2022 May 11.
help

What are the analyst ratings for Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock?

The analyst ratings for Biohaven Pharmaceutical Holding Co Ltd (BHVN) are distributed as follows: 16 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Biohaven Pharmaceutical Holding Co Ltd.
help

What is the AI price prediction for Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock?

At present, there is no AI or machine-learning-based price prediction available for Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level